Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 4007
118th Congress(2023-2024)
HEAL Act of 2023
Introduced
Introduced
Introduced in House on Jun 12, 2023
Overview
Text
Introduced in House 
Jun 12, 2023
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jun 12, 2023)
Jun 12, 2023
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 4007 (Introduced-in-House)


118th CONGRESS
1st Session
H. R. 4007


To ensure references to opioid overdose reversal agents in grant programs of the Department of Health and Human Services are not limited to naloxone.

IN THE HOUSE OF REPRESENTATIVES

June 12, 2023

Mr. Armstrong (for himself and Mr. Tonko) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To ensure references to opioid overdose reversal agents in grant programs of the Department of Health and Human Services are not limited to naloxone.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Halting the Epidemic of Addiction and Loss Act of 2023” or the “HEAL Act of 2023”.

SEC. 2. References to opioid overdose reversal agents in HHS grant programs.

(a) In general.—The Secretary of Health and Human Services shall ensure that, whenever the Department of Health and Human Services issues a regulation, guidance, or other document for any grant program addressing opioid misuse and use disorders, any reference to an opioid overdose reversal agent (such as a reference to naloxone) is inclusive of any opioid overdose reversal agent that has been approved or otherwise authorized for use by the Food and Drug Administration.

(b) Existing references.—

(1) UPDATE.—Not later than the end of calendar year 2023, the Secretary of Health and Human Services shall update all references described in paragraph (2) to be inclusive of any opioid overdose reversal agent that has been approved or otherwise authorized for use by the Food and Drug Administration.

(2) REFERENCES.—A reference described in this paragraph is any reference to an opioid overdose reversal agent (such as naloxone) in any regulation, guidance, or other document of the Department of Health and Human Services that—

(A) was issued before the date of enactment of this Act; and

(B) is for—

(i) the grant program for State and Tribal response to opioid use disorders under section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee–3 note; commonly referred to as “State Opioid Response Grants” and “Tribal Opioid Response Grants”); or

(ii) the grant program for priority substance use disorder prevention needs of regional and national significance under section 516 of the Public Health Service Act (42 U.S.C. 290bb–22).